Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46

1.

Immunocompetent murine models for the study of glioblastoma immunotherapy.

Oh T, Fakurnejad S, Sayegh ET, Clark AJ, Ivan ME, Sun MZ, Safaee M, Bloch O, James CD, Parsa AT.

J Transl Med. 2014 Apr 29;12:107. doi: 10.1186/1479-5876-12-107.

PMID:
24779345
[PubMed - in process]
Free PMC Article
2.

Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors.

Yang W, Barth RF, Huo T, Nakkula RJ, Weldon M, Gupta N, Agius L, Grecula JC.

Radiat Oncol. 2014 Jan 14;9:25. doi: 10.1186/1748-717X-9-25.

PMID:
24422671
[PubMed - in process]
Free PMC Article
3.

Early gene expression analysis in 9L orthotopic tumor-bearing rats identifies immune modulation in molecular response to synchrotron microbeam radiation therapy.

Bouchet A, Sakakini N, El Atifi M, Le Clec'h C, Brauer E, Moisan A, Deman P, Rihet P, Le Duc G, Pelletier L.

PLoS One. 2013 Dec 31;8(12):e81874. doi: 10.1371/journal.pone.0081874. eCollection 2013.

PMID:
24391709
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Biodistribution and subcellular localization of an unnatural boron-containing amino acid (cis-ABCPC) by imaging secondary ion mass spectrometry for neutron capture therapy of melanomas and gliomas.

Chandra S, Barth RF, Haider SA, Yang W, Huo T, Shaikh AL, Kabalka GW.

PLoS One. 2013 Sep 18;8(9):e75377. doi: 10.1371/journal.pone.0075377. eCollection 2013.

PMID:
24058680
[PubMed - in process]
Free PMC Article
5.

Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma.

Lee CC, Lai JH, Hueng DY, Ma HI, Chung Y, Sun YY, Tsai YJ, Wu WB, Chen CL.

Cancer Cell Int. 2013 Aug 21;13(1):85. doi: 10.1186/1475-2867-13-85.

PMID:
23961808
[PubMed]
Free PMC Article
6.

Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models.

He T, Smith N, Saunders D, Pittman BP, Lerner M, Lightfoot S, Silasi-Mansat R, Lupu F, Towner RA.

Am J Nucl Med Mol Imaging. 2013 Jul 10;3(4):300-11. Print 2013.

PMID:
23901356
[PubMed]
Free PMC Article
7.

Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon.

Zemp FJ, McKenzie BA, Lun X, Maxwell L, Reilly KM, McFadden G, Yong VW, Forsyth PA.

PLoS One. 2013 Jun 6;8(6):e65801. doi: 10.1371/journal.pone.0065801. Print 2013.

PMID:
23762429
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model.

Aryal M, Vykhodtseva N, Zhang YZ, Park J, McDannold N.

J Control Release. 2013 Jul 10;169(1-2):103-11. doi: 10.1016/j.jconrel.2013.04.007. Epub 2013 Apr 18.

PMID:
23603615
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study.

Wei KC, Chu PC, Wang HY, Huang CY, Chen PY, Tsai HC, Lu YJ, Lee PY, Tseng IC, Feng LY, Hsu PW, Yen TC, Liu HL.

PLoS One. 2013;8(3):e58995. doi: 10.1371/journal.pone.0058995. Epub 2013 Mar 19.

PMID:
23527068
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.

Floyd RA, Castro Faria Neto HC, Zimmerman GA, Hensley K, Towner RA.

Free Radic Biol Med. 2013 Sep;62:145-56. doi: 10.1016/j.freeradbiomed.2013.01.033. Epub 2013 Feb 16. Review.

PMID:
23419732
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Assessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy.

Hou H, Mupparaju SP, Lariviere JP, Hodge S, Gui J, Swartz HM, Khan N.

Radiat Res. 2013 Mar;179(3):343-51. doi: 10.1667/RR2811.1. Epub 2013 Feb 7.

PMID:
23391148
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Detection of remote neuronal reactions in the Thalamus and Hippocampus induced by rat glioma using the PET tracer cis-4-[¹⁸F]fluoro-D-proline.

Geisler S, Willuweit A, Schroeter M, Zilles K, Hamacher K, Galldiks N, Shah NJ, Coenen HH, Langen KJ.

J Cereb Blood Flow Metab. 2013 May;33(5):724-31. doi: 10.1038/jcbfm.2013.8. Epub 2013 Feb 6.

PMID:
23385199
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model.

Bidwell GL 3rd, Perkins E, Hughes J, Khan M, James JR, Raucher D.

PLoS One. 2013;8(1):e55104. doi: 10.1371/journal.pone.0055104. Epub 2013 Jan 25.

PMID:
23372821
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007.

Towner RA, Gillespie DL, Schwager A, Saunders DG, Smith N, Njoku CE, Krysiak RS 3rd, Larabee C, Iqbal H, Floyd RA, Bourne DW, Abdullah O, Hsu EW, Jensen RL.

Neuro Oncol. 2013 Mar;15(3):330-40. doi: 10.1093/neuonc/nos337. Epub 2013 Jan 17.

PMID:
23328810
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Diffusion tensor magnetic resonance imaging of rat glioma models: a correlation study of MR imaging and histology.

Wang S, Zhou J.

J Comput Assist Tomogr. 2012 Nov-Dec;36(6):739-44. doi: 10.1097/RCT.0b013e3182685436.

PMID:
23192213
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Preparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats.

Huo T, Barth RF, Yang W, Nakkula RJ, Koynova R, Tenchov B, Chaudhury AR, Agius L, Boulikas T, Elleaume H, Lee RJ.

PLoS One. 2012;7(11):e48752. doi: 10.1371/journal.pone.0048752. Epub 2012 Nov 13.

PMID:
23152799
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

ELTD1, a potential new biomarker for gliomas.

Towner RA, Jensen RL, Colman H, Vaillant B, Smith N, Casteel R, Saunders D, Gillespie DL, Silasi-Mansat R, Lupu F, Giles CB, Wren JD.

Neurosurgery. 2013 Jan;72(1):77-90; discussion 91. doi: 10.1227/NEU.0b013e318276b29d.

PMID:
23096411
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Growth properties of SF188/V+ human glioma in rats in vivo observed by magnetic resonance imaging.

Grossman R, Tyler B, Brem H, Eberhart CG, Wang S, Fu DX, Wen Z, Zhou J.

J Neurooncol. 2012 Dec;110(3):315-23. doi: 10.1007/s11060-012-0974-5. Epub 2012 Sep 27.

PMID:
23011120
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model.

Mineharu Y, Muhammad AK, Yagiz K, Candolfi M, Kroeger KM, Xiong W, Puntel M, Liu C, Levy E, Lugo C, Kocharian A, Allison JP, Curran MA, Lowenstein PR, Castro MG.

Neurotherapeutics. 2012 Oct;9(4):827-43. doi: 10.1007/s13311-012-0144-7.

PMID:
22996231
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The cell death of C6 astrocytoma cells induced by oridonin and its mechanism.

Yin B, Sheng H, Lin J, Zhou H, Zhang N.

Int J Clin Exp Pathol. 2012;5(6):562-8. Epub 2012 Jul 29.

PMID:
22949939
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk